Kancera AB (publ) (KAN.ST)

SEK 1.22

(9.09%)

Inventory Summary of Kancera AB (publ)

  • Kancera AB (publ)'s latest annual inventory in 2023 was -1950.00 SEK , up 55.08% from previous year.
  • Kancera AB (publ)'s latest quarterly inventory in 2024 Q2 was -1.93 Million SEK , up 100.0% from previous quarter.
  • Kancera AB (publ) reported annual inventory of -4341.00 SEK in 2022, down -101.86% from previous year.
  • Kancera AB (publ) reported annual inventory of 234 Thousand SEK in 2021, up 3895.0% from previous year.
  • Kancera AB (publ) reported quarterly inventory of -1.93 Million SEK for 2024 Q2, up 100.0% from previous quarter.
  • Kancera AB (publ) reported quarterly inventory of -3395.00 SEK for 2023 Q2, up 54.4% from previous quarter.

Annual Inventory Chart of Kancera AB (publ) (2023 - 2010)

Historical Annual Inventory of Kancera AB (publ) (2023 - 2010)

Year Inventory Inventory Growth
2023 -1950.00 SEK 55.08%
2022 -4341.00 SEK -101.86%
2021 234 Thousand SEK 3895.0%
2020 -6166.00 SEK 0.0%
2019 - SEK 0.0%
2018 - SEK -100.0%
2017 1.58 Million SEK -72.57%
2016 5.76 Million SEK 287.62%
2015 1.48 Million SEK -45.08%
2014 2.7 Million SEK 0.0%
2013 - SEK -100.0%
2012 871 Thousand SEK 0.0%
2011 - SEK 0.0%
2010 - SEK 0.0%

Peer Inventory Comparison of Kancera AB (publ)

Name Inventory Inventory Difference
Alligator Bioscience AB (publ) 2.00 SEK 97600.0%
Ziccum AB (publ) -4.18 Million SEK 99.953%
Modus Therapeutics Holding AB (publ) - SEK Infinity%
BioArctic AB (publ) - SEK Infinity%
Sprint Bioscience AB (publ) -7.13 Million SEK 99.973%
Mendus AB (publ) - SEK Infinity%
Genovis AB (publ.) 14.9 Million SEK 100.013%
Intervacc AB (publ) 10.48 Million SEK 100.019%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK Infinity%
Active Biotech AB (publ) -2500.00 SEK 22.0%
Magle Chemoswed Holding AB (publ) 35.22 Million SEK 100.006%
Bio-Works Technologies AB (publ) 9.06 Million SEK 100.022%
Aptahem AB (publ) - SEK Infinity%
Vicore Pharma Holding AB (publ) - SEK Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK Infinity%
Fluicell AB (publ) 3.15 Million SEK 100.062%
Saniona AB (publ) 1.00 SEK 195100.0%
Lipigon Pharmaceuticals AB (publ) -1.62 Million SEK 99.88%
Biovica International AB (publ) 2.19 Million SEK 100.089%
Spago Nanomedical AB (publ) 1.00 SEK 195100.0%
AcouSort AB (publ) 2.08 Million SEK 100.094%
Xintela AB (publ) 398 Thousand SEK 100.49%
Abliva AB (publ) - SEK Infinity%
Egetis Therapeutics AB (publ) 700 Thousand SEK 100.279%
Karolinska Development AB (publ) - SEK Infinity%
OncoZenge AB (publ) -862.99 Thousand SEK 99.774%
Amniotics AB (publ) 534 Thousand SEK 100.365%
2cureX AB (publ) -1000.00 SEK -95.0%
CombiGene AB (publ) -1.79 Million SEK 99.892%
Asarina Pharma AB (publ) - SEK Infinity%
Calliditas Therapeutics AB (publ) 20.42 Million SEK 100.01%
Camurus AB (publ) 100.95 Million SEK 100.002%
Corline Biomedical AB -3.85 Million SEK 99.949%
IRLAB Therapeutics AB (publ) 1000.00 SEK 295.0%
Isofol Medical AB (publ) - SEK Infinity%
I-Tech AB 4.28 Million SEK 100.046%
Hansa Biopharma AB (publ) 9.79 Million SEK 100.02%
Cyxone AB (publ) - SEK Infinity%
ExpreS2ion Biotech Holding AB (publ) - SEK Infinity%
Biosergen AB -4.92 Million SEK 99.96%
Cantargia AB (publ) - SEK Infinity%
NextCell Pharma AB 545.23 Thousand SEK 100.358%
Xspray Pharma AB (publ) 43.78 Million SEK 100.004%
Elicera Therapeutics AB (publ) -446.98 Thousand SEK 99.564%
Nanologica AB (publ) 2.97 Million SEK 100.066%
SynAct Pharma AB - SEK Infinity%
Annexin Pharmaceuticals AB (publ) - SEK Infinity%
Stayble Therapeutics AB (publ) -321.14 Thousand SEK 99.393%
LIDDS AB (publ) - SEK Infinity%
Lipum AB (publ) - SEK Infinity%
BioInvent International AB (publ) 11.84 Million SEK 100.016%
Alzinova AB (publ) -3.27 Million SEK 99.941%
Oncopeptides AB (publ) 2.42 Million SEK 100.08%
Pila Pharma AB (publ) 1.00 SEK 195100.0%
Guard Therapeutics International AB (publ) -1486.00 SEK -31.225%
Scandinavian ChemoTech AB (publ) 4.03 Million SEK 100.048%
Simris Alg AB (publ) 1.09 Million SEK 100.179%
Diamyd Medical AB (publ) 24.05 Million SEK 100.008%
Xbrane Biopharma AB (publ) 106.85 Million SEK 100.002%
Ascelia Pharma AB (publ) - SEK Infinity%
Diagonal Bio AB (publ) 1.02 Million SEK 100.19%